Quarterly
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||
net income | -24,685,000 | -9,810,000 | -10,288,767 | -9,959,164 | -54,896,438 | 1,528,369 | 2,576,373 | 2,418,722 | 3,782,431 | 3,090,679 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||
depreciation and amortization | 125,000 | 124,000 | 87,580 | 68,747 | ||||||
change in fair value of simple agreements for future equity | -2,055,959 | 0 | ||||||||
accretion of discount on marketable debt securities | -30,000 | -312,000 | -258,855 | |||||||
stock-based compensation | 11,365,000 | 2,311,000 | 1,733,220 | 1,626,364 | ||||||
deferred income taxes | 0 | -4,734,000 | ||||||||
change in operating assets and liabilities, net of effect of acquisition: | ||||||||||
prepaid and other current assets | -4,349,000 | 336,000 | -686,798 | 607,986 | ||||||
other assets | -4,000 | -17,000 | -25,361 | -115,000 | ||||||
accounts payable | -701,000 | -1,755,000 | 162,326 | -331,371 | ||||||
accrued expenses and other | -216,000 | 1,606,000 | -2,134,339 | 153,173 | ||||||
operating lease right-of-use assets and liabilities | 24,000 | 8,000 | ||||||||
net cash from operating activities | -18,471,000 | -12,243,000 | -13,469,362 | -7,880,489 | -15,832,264 | -1,207,885 | -3,164,239 | -3,457,143 | -3,544,284 | -678,937 |
capex | -877,000 | -332,000 | -69,381 | -110,886 | 0 | 0 | 0 | 0 | 0 | 0 |
free cash flows | -19,348,000 | -12,575,000 | -13,538,743 | -7,991,375 | -15,832,264 | -1,207,885 | -3,164,239 | -3,457,143 | -3,544,284 | -678,937 |
cash flows from investing activities: | ||||||||||
purchases of property and equipment | -877,000 | -332,000 | -69,381 | -110,886 | ||||||
purchases of marketable debt securities | -316,717,000 | -29,887,000 | -30,538,322 | |||||||
proceeds from redemptions of marketable debt securities | 30,834,000 | 37,183,000 | 48,804,940 | |||||||
payment for acquisition of business, net of cash acquired | 0 | -900,000 | ||||||||
net cash from investing activities | 18,197,237 | -5,608,340 | 218,958,186 | 4,366,333 | ||||||
cash flows from financing activities: | ||||||||||
proceeds from recapitalization | 232 | 0 | ||||||||
payment of taxes from common stock withheld | 0 | -1,595,000 | ||||||||
proceeds from exercise of stock options | 628,000 | 720,000 | 604,078 | 0 | ||||||
proceeds from right of first refusal liability | 0 | 0 | ||||||||
proceeds from simple agreements for future equity | 0 | 0 | ||||||||
payment of offering costs and deferred issuance costs | ||||||||||
proceeds from common stock public offering, net of offering | ||||||||||
net cash from financing activities | 441,924,000 | -875,000 | 603,959 | -388,189 | ||||||
net increase in cash and cash equivalents | 136,693,000 | -7,054,000 | 5,331,834 | -13,877,018 | ||||||
cash and cash equivalents - beginning of period | 0 | 97,132,000 | ||||||||
cash and cash equivalents - end of period | 136,693,000 | 90,078,000 | ||||||||
supplemental disclosures of cash flow information: | ||||||||||
cash paid for income taxes | 550,110 | 1,967,829 | 2,205,000 | |||||||
supplemental noncash investing and financing activities: | ||||||||||
issuance of common stock in connection with acquisition of business | 0 | 27,408,000 | ||||||||
assumed liabilities in connection with acquisition of business | 0 | 287,000 | ||||||||
purchases of property and equipment in accounts payable and accrued expense and other | ||||||||||
offering costs included in accounts payable | ||||||||||
offering costs included in accrued expense and other | ||||||||||
deferred issuance costs included in accounts payable | ||||||||||
deferred issuance costs included in accrued expense and other | ||||||||||
reclassification of simple agreements for future equity in connection with business combination | -2,055,959 | 0 | ||||||||
reclassification of deferred issuance costs in connection with business combination | 1,905,765 | -388,189 | ||||||||
net cash from investing activities: | 6,064,000 | |||||||||
payment of deferred issuance costs | -351 | -388,189 | ||||||||
cash flows from operating activities | ||||||||||
change in operating assets and liabilities: | ||||||||||
cash flows from investing activities | ||||||||||
cash flows from financing activities | ||||||||||
cash and cash equivalents - beginning of year | 412 | |||||||||
cash and cash equivalents - end of year | ||||||||||
supplemental disclosures of cash flow information | ||||||||||
cash paid for interest | ||||||||||
supplemental noncash investing and financing activities | ||||||||||
purchases of computer software in accounts payable and accrued expense and other | ||||||||||
operating lease liabilities | ||||||||||
accretion of discount on marketable securities | ||||||||||
operating lease liability | ||||||||||
purchase of marketable securities | ||||||||||
proceeds from redemptions of marketable securities | ||||||||||
cash and cash equivalents – beginning of year | ||||||||||
cash and cash equivalents – end of period | ||||||||||
supplemental disclosure of cash flow information | ||||||||||
interest earned on marketable securities held in trust account | -3,952,338 | -5,862,881 | -5,416,834 | |||||||
unrealized loss on marketable securities held in trust account | ||||||||||
deferred tax benefit | -294,084 | |||||||||
changes in operating assets and liabilities: | ||||||||||
prepaid expenses | 149,860 | -398,470 | 10,250 | 231,664 | 146,664 | |||||
accrued expenses | 412,148 | -627,092 | 778,607 | -285,858 | 331,764 | |||||
income taxes payable | 654,076 | -409,150 | -19,270 | -1,356,786 | 1,410,020 | |||||
| ||||||||||
net change in cash | -1,207,885 | -120,726 | 909,190 | |||||||
cash – beginning of period | 1,628,692 | 0 | 0 | 3,577,359 | ||||||
cash – end of period | 420,807 | 909,190 | -2,058,194 | 2,898,422 | ||||||
non-cash investing and financing activities: | ||||||||||
remeasurement for class a common stock to redemption amount | 1,495,821 | |||||||||
class a common stock subject to possible redemption, december 31, 2022 | 504,544,687 | 0 | 0 | 0 | 504,544,687 | |||||
less: | ||||||||||
redemptions | -215,914,673 | |||||||||
plus: | ||||||||||
remeasurement of carrying value to redemption value | 14,785,760 | 0 | 0 | 0 | 31,196,812 | |||||
class a common stock subject to possible redemption, december 31, 2023 | 303,415,774 | |||||||||
class a common stock subject to possible redemption, march 31, 2024 | 304,911,595 | |||||||||
cash withdrawn from trust account to pay franchise and income taxes | 3,043,513 | 3,366,333 | ||||||||
cash withdrawn from trust account for working capital purposes | 0 | |||||||||
cash withdrawn from trust account in connection with redemption | ||||||||||
redemptions of common stock | ||||||||||
cash — beginning of period | ||||||||||
cash — end of period | ||||||||||
supplemental cash flow information: | ||||||||||
deferred underwriting fee payable | ||||||||||
excise tax liability accrued for common stock redemptions | ||||||||||
gross proceeds | 0 | 0 | 0 | 500,000,000 | ||||||
class a common stock issuance costs | 0 | 0 | 0 | -26,652,125 | ||||||
interest earned on cash and marketable securities held in trust account | ||||||||||
deferred tax provision | 0 | |||||||||
re-measurement for class a common stock to redemption amount | 3,216,277 | |||||||||
re-measurement of carrying value to redemption value | 4,375,351 | 4,633,931 | 3,216,277 | |||||||
class a common stock subject to possible redemption, september 30, 2023 | ||||||||||
unrealized gain on marketable securities held in trust account | ||||||||||
class a common stock subject to possible redemption, june 30, 2023 | ||||||||||
unrealized gain gain on marketable securities held in trust account | 52,854 | |||||||||
net decrease in cash | -678,937 | |||||||||
offering costs included in accrued offering costs | ||||||||||
class a common stock subject to possible redemption, march 31, 2023 | 507,760,964 | |||||||||
proceeds from issuance of class b common stock to sponsor | ||||||||||
proceeds from promissory note - related party | ||||||||||
payment of offering costs | ||||||||||
accretion of carrying value to redemption value | ||||||||||
class a common stock subject to possible redemption | ||||||||||
3.1 | ||||||||||
10.1 | ||||||||||
10.2 | ||||||||||
10.3 | ||||||||||
10.4 | ||||||||||
10.5 | ||||||||||
10.6 | ||||||||||
31.1* | ||||||||||
31.2* | ||||||||||
32.1** | ||||||||||
32.2** | ||||||||||
101.ins | ||||||||||
101.sch | ||||||||||
101.cal | ||||||||||
101.def | ||||||||||
101.lab | ||||||||||
101.pre | ||||||||||
104 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
